Favipiravir drug shows promise against Chandipura virus in preclinical studies by NIV

Favipiravir offers hope against the Chandipura virus. Studies by the National Institute of Virology show promising results. The drug reduces viral load in infected animals. Chandipura outbreaks have occurred in India, affecting children. A major outbreak happened in 2024. Clinical trials on humans are pending. Research is underway for a vaccine. Current treatment focuses on managing symptoms.

from Healthcare/Biotech-Industry-Economic Times https://ift.tt/3G4jsPE
via IFTTT